Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Sánchez-Mascuñano, Alba et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/122506

Relationship of altitude mountain sickness and smoking: a Catalan traveller's cohort study

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Objectives: The aim of this study is to analyse the relationship between smoking and altitude mountain sickness in a cohort of travellers to 2500 metres above sea level (masl) or higher. Setting: Travel Health Clinic at the Hospital Universitari de Bellvitge, in Barcelona, Spain. Participants: A total of 302 adults seeking medical advice at the travel clinic, between July 2012 and August 2014, before travelling to 2500 masl or above, who agreed to participate in the study and to be contacted after the trip were included. Individuals who met the following criteria were excluded: younger than 18 years old, taking carbonic anhydrase inhibitors for chronic use, undergoing treatment with systemic corticosteroids and taking any medication that might prevent or treat altitude mountain sickness (AMS) prior to or during the trip. The majority of participants were women (n=156, 51.7%). The mean age was 37.7 years (SD 12.3). The studied cohort included 74 smokers (24.5%), 158 (52.3%) non-smokers and 70 (23.2%) ex-smokers. No statistical differences were observed between different sociodemographic characteristics, constitutional symptoms or drug use and smoking status. Outcomes: The main outcome was the development of AMS, which was defined according to the Lake Louise AMS criteria. Results: AMS, according to the Lake Louise score, was significantly lower in smokers; the value was 14.9%, 95% CI (6.8 to 23.0%) in smokers and 29.4%, 95% CI (23.5 to 35.3%) in non-smokers with an adjusted OR of 0.54, 95% CI (0.31 to 0.97) independent of gender, age and maximum altitude reached. Conclusions: These results suggest that smoking could reduce the risk of AMS in non-acclimated individuals. Further studies should be performed in larger cohorts of travellers to confirm these results. Despite the results, smoking must be strongly discouraged because it greatly increases the risk of cardiorespiratory diseases, cancer and other diseases.

Citation

Citation

SÁNCHEZ-MASCUÑANO, Alba, et al. Relationship of altitude mountain sickness and smoking: a Catalan traveller's cohort study. BMJ Open. 2017. Vol. 7, num. 9, pags. e017058. ISSN 2044-6055. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/122506

Export metadata

JSON - METS

Share record